Info Day “Innovative processes & formulations to answer current market trends in OSD forms” POSTPONED 20 JUNE 2023



Registration details on bottom page

In addition Medelpharm organizes a workshop in its facilities on 30 January and 1 February,

details here

                                               31 January – Schedule
8:30-9:00Welcome coffee
9:00-9:20Information on partners & programme
9:20-10:00Challenges in oral application, new technologies, and their opportunities
 Dr Vanessa Bourgeaux, Pharmaceutical Development Project Manager – Skyepharma
 Bruno Leclercq – Medelpharm
 Dr Gernot Warnke, Head of R&D – JRS
10:00-10:40General considerations in compression
 Adrien Pelloux – Medelpharm
10:40-11:10Coffee break
11:10-11:50Nanoencapsulation: a new era for oral solid dosage forms
 Oksana Lemasson – LAGEPP
11:50-12:10Tab-in-tab: a versatile approach to address multiple unmet needs
 Dr Vanessa Bourgeaux, Pharmaceutical Development Project Manager – Skyepharma
12:10-12:30Soctec: an innovative gastro-retentive formulation
 Pauline Tarlet – Skyepharma
13:40-14:20Compaction of sensitive Probiotics
 Dr Susanne Florin-Muschert – University of Lille
 Dr Gernot Warnke, Head of R&D – JRS
14:20-15:00Introducing a Novel Formulation Approach for Poorly Water Soluble APIs
 Dr Gernot Warnke, Head of R&D – JRS
15:00-15:30Coffee break
15:30-16:10Challenges and innovations in TiO2 free coatings
 Alireza Ramtin, Technical Sales Manager – JRS
16:10-16:50Using rheometry to accelerate your formulation development and control quality
 Scott Humphries, Technical Sales Manager – Caleva
16:50-17:00Closing remarks

Fees and registration
Free for APGI members in 2023. Non APGI members are asked to become members for the year 2023. Being member will also allow you to benefit from reduced or waived registration fees for other APGI events in 2023. If you are APGI member for 2022 and you want to assist to this Info Day, please renew your membership before registration.

  • Students 25€ + 20% french VAT
  • Academics 90€ + 20% french VAT
  • Industrials 220€ + 20% french VAT
  • Retirees 25€ + 20% french VAT

Registration is open, go to bottom page

Institue Lumière
25 rue du Premier Film
69352 Lyon Cédex 08

Institut Lumière is located 10 mn from Part-Dieu station and 15 mn from Perache station. Subway: line D station “Monplaisir Lumière”

Our speakers

Dr Vanessa Bourgeaux, Pharmaceutical Development Project Manager, Skyepharma

Vanessa BOURGEAUX brings 15 years of experience in R&D and pharmaceutical development. She initiated her career at erytech pharma (Lyon, France), where she held the position of global project leader and actively contributed to the development of erythrocytes as drug carriers for oncology and sickle cell disease. In 2020, Vanessa joined Skyepharma, a CDMO specialized in solid oral dosage forms. As project manager in New Product Introduction department, her mission is oriented towards Innovation and collaborative partnerships. Vanessa graduated in organic chemistry and holds a PhD in biochemistry and cellular biology. She is author of 13 publication and 12 patents.

Dr Susanne Florin-Muschert, University of Lille

Since 2010, I’m working as an Associate Professor (tenure) at the University of Lille and fulfill several academic functions, such as the establishment of academic curriculums (especially of the Master 2 Diploma “Pharmacie galénique” and graduate programs for Pharmacy. I am also a member of several workgroup for educational development within the faculty of Pharmacy.

My research work is focused on formulating solid oral dosage forms for controlled release and takes place in the INSERM U 1008 “Advanced Drug Delivery Systems”. I am/was conducting several research projects (in collaboration with industrial partners, such as BASF, Merck Sharp and Dohme, Seppic, Evonik, Lallemand, Lattice Medical& Cousin Biotech), managed the Work package in two Interreg Projects (European Union funding) and collaborated with academic institutions, such as the University of Saarbrucken, Lund and Ghent. Tutoring of PhD students and Master students is also one of my functions.

Schott Humphries, Technical Sales Manager, Caleva

Scott Humphries joined Caleva in 2017 as Technical Sales Manager for the UK, Europe and Middle East Regions. With over 25 years’ experience working with a diverse range of customers in both laboratory and production environments, Scott has a proven ability to help customers overcome complex processing challenges.

Bruno Leclercq, Head of MEDELPHARM Science Lab / Business Development

Bruno Leclercq is a senior pharmacist working in business development at Medelpharm, headquartered in Lyon, France, an international company dedicated to a continuous search for innovative solutions in powder compression and processing technologies in order to create the ultimate tool for scientists in R&D.

Its renowned STYL’One Tableting Instrument has become an industry standard for compaction simulation and challenging powder characterization as well as small scale development in the pharmaceutical industry.

Bruno is an experienced pharmaceutical technical Manager with extensive knowledge in solid form technology and processes. He can look back to more than 15 years of International experience in meeting, advising and solving customers’ formulations and production problems in Europe, SEA und the US.

Oksana Lemasson, LAGEPP

Oksana LEMASSON obtained a double degree in pharmacy and a master 2 in industrial cosmetology with a specialization in formulation at the University of Lyon (France). Following her studies, she taught galenics for a year at University to pharmacy students. Wishing to develop her expertise in formulation, she is currently a PhD student at LAGEPP (Lyon, France), in partnership with Skyepharma, and works on the development of lipid-based nanoparticles, from proof of concept to manufacturing process optimization.

Adrien Pelloux, Application laboratory manager, Medelpharm

Pharmacist by training, he has held different positions in the pharmaceutical industry, as a liquid and solid manufacturing unit manager, and then as a technical transfer and support manager.

He is currently heading the Medelpharm Science Laboratory, and perform customer trials (powder characterization and compression trials), consulting on tableting issues and trainings. He supports the engineering department on the development of innovative accessories for the STYL’One family.

His area of expertise extends from the physics of powder compaction, transfer of analytical methods, industrial transfers, production management and statistical data analysis.

Alireza Ramtin, Technical Sales Manager, JRS Pharma

Alireza Ramtin is the Technical Sales Manager at JRS Pharma, Coating department. In this role, he is responsible for supporting the customer technically, developing new products with co-operation with JRS Pharma’s R&D team and promoting and selling new products. Alireza Studied Pharmacy at RGUHS University in India followed by a master degree in Bio- and Pharmaceutical analysis in Germany. He enters Coating market in 2016 and he has held different positions like deputy head of R&D.

Pauline TARLET, Skyepharma

Pauline TARLET graduated from CPE Lyon, an engineering school in chemistry, with a specialization in formulation. During her final year internship at Skyepharma, she worked on the development of a gastro-retentive formulation. With the aim of increasing her technical knowledge in galenic development, she is starting a PhD at LAGEPP and Skyepharma, working on the development of a platform of mucoadhesive formulation targeting the gastrointestinal tract.

Dr Gernot Warnke, Head of JRS Pharma’s R&D

In this role, he is responsible for the global network of JRS laboratories offering technical support to customers, carrying out application studies and developing new products for JRS Pharma’s portfolio of excipients and film coatings.

Dr Warnke studied pharmacy in Freiburg, Germany, and holds a PhD in pharmaceutical technology. He has over 20 years of experience in the field of pharmaceutical excipients, having worked with major manufacturers of cellulose derivatives and lactose prior to joining JRS Pharma.